Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Depreciation and Depletion (2024 - 2025)

Historic Depreciation and Depletion for Cytosorbents (CTSO) over the last 4 years, with Q3 2025 value amounting to $300000.0.

  • Cytosorbents' Depreciation and Depletion changed 0.0% to $300000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 6513.97%. This contributed to the annual value of $1.3 million for FY2024, which is 820.12% up from last year.
  • Cytosorbents' Depreciation and Depletion amounted to $300000.0 in Q3 2025, which was down 0.0% from $294300.0 recorded in Q2 2025.
  • In the past 5 years, Cytosorbents' Depreciation and Depletion ranged from a high of $457800.0 in Q2 2024 and a low of $294300.0 during Q2 2025